Langford, United Kingdom
Langford, United Kingdom

Time filter

Source Type

We deeply analyzed Europe, the Middle East and Africa growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate — Europe, the Middle East and Africa Cell Counting Market– Forecast to 2021 The report firstly introduced Europe, the Middle East and Africa Cell Counting Market including classification, application and industry chain overview; Then we deeply analyzed Europe, the Middle East and Africa growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate etc. In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Europe, the Middle East and Africa Cell Counting Market. We are thankful for the support and assistance from Europe, the Middle East and Africa Cell Counting Market chain related technical experts and marketing experts during Research Team survey and interviews. 6 Europe, The Middle East And Africa Cell Counting Market, By End Users 6.1 Introduction 6.2 Hospitals And Research Institutions 6.3 Diagnostic Laboratories 6.4 Pharmaceutical & Biotechnology Companies, And Cros 6.5 Others 7 Europe, The Middle East And Africa Cell Counting Market, By Pharmacological Treatments 7.1 Introduction 7.2 Consumables 7.2.1 Reagents 7.2.2 Assay Kits 7.2.3 Microplates 7.2.4 Others 7.3 Instruments 7.3.1 Spectrophotometers 7.3.1.1 Single-Mode Readers 7.3.1.2 Multi-Mode Readers 7.3.2 Flow Cytometers 7.3.3 Cell Counters 7.3.3.1 Automated Cell Counters 7.3.3.2 Hemocytometers And Manual Cell Counters 7.3.4 Hematology Analyzers 7.4 Accessories 8 Europe, The Middle East And Africa Cell Counting Market, By Application 6.1 Introduction 6.2 Research 6.3 Diagnostic 6.4 Quality Testing 6.5 Others 9 Geographical Exploration 9.1 Introduction 9.2 Europe 9.2.1 Germany 9.2.2 France 9.2.3 U.K. 9.2.4 Italy 9.2.5 Spain 9.2.6 Rest Of Europe 9.3 Middle East & Africa 10 Competitive Analysis 11 Company Profiles 12 Appendix 12.1 Discussion Blue Print 12.2 Industry Expert Quotes 12.3 Bibliography For more information, please visit https://www.marketresearchfuture.com/reports/europe-cell-counting-market


DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "India Diagnostic Laboratories Market Outlook to 2021 Growing Prevalence of Diseases and Launch of Technologically Advanced Procedures to Drive Growth" report to their offering. The report includes the cumulative revenue generated by the market players from diagnostic services including both government and private diagnostic laboratories. The private diagnostic laboratories has been further explained with details on market share contributed by pathology tests and radiology tests, by Tier I, Tier II and Tier III Cities, and by hospital based diagnostic laboratories, polyclinics and independent diagnostic laboratories operating in India. The share by organized and unorganized players has also been provided in detail to clearly explain the present competition scenario in the market. The stakeholders of this report include diagnostic laboratories market players, laboratories equipments providers, companies involved in research and development activities, and the new entrants and venture capitalists who wish to invest in diagnostic laboratories market in future. Detailed snapshot on pathology tests market and radiology tests market is included in the report to elucidate facts about the market in detail. Various marketing analysis factors such as trends and developments, regulatory framework and Porter's five forces analysis are also added in the study for clear understanding about the factors responsible for present scenario of the market. The future analysis of overall India diagnostic laboratories market has also been discussed along with recommendations from analyst view. For more information about this report visit http://www.researchandmarkets.com/research/ssxwxk/india_diagnostic


Receive press releases from iHealthcareAnalyst, Inc.: By Email Multiplexed Molecular Diagnostics Market by Technologies, Applications, End Users, Growth Trends and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc. Multiplexed Molecular Diagnostics Market by Technology (Low Density Multiplexed Assays, Medium Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays, Next Generation Sequencing Assays), Application (Allergies, Autoimmune Diseases, Cardiac Diseases, Infectious Disease Diagnostic, Oncology, Pregnancy & Fertility Testing), End Users (Academic Research Institutes, Clinical Research Organizations, Diagnostic Laboratories, Hospital, Pharmaceutical Companies) Maryland Heights, MO, April 27, 2017 --( Browse Multiplexed Molecular Diagnostics Market by Technology (Low Density Multiplexed Assays, Medium Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays, Next Generation Sequencing Assays), Application (Allergies, Autoimmune Diseases, Cardiac Diseases, Infectious Disease Diagnostic, Oncology, Pregnancy & Fertility Testing), End Users (Academic Research Institutes, Clinical Research Organizations, Diagnostic Laboratories, Hospital, Pharmaceutical Companies) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/ The global multiplexed molecular diagnostics market segmentation is based on technology (low density multiplexed assays, medium density multiplexed assays, high density multiplexed assays, very high density multiplexed assays, next generation sequencing assays), application (allergies, autoimmune diseases, cardiac diseases, infectious disease diagnostic, oncology, pregnancy & fertility testing), end users (academic research institutes, clinical research organizations, diagnostic laboratories, hospital, pharmaceutical companies). The global multiplexed molecular diagnostics market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global multiplexed diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global multiplexed molecular diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. Major players operating in the global multiplexed molecular diagnostics market and profiled in this report include Abbott Laboratories, Agilent Technologies, bioMérieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Luminex Corporation, Siemens Healthineers, and Thermo Fisher Scientific, Inc. 1. Technology 1.1. Low Density Multiplexed Assays (plex ≤ 5) 1.2. Medium Density Multiplexed Assays (plex < 500) 1.3. High Density Multiplexed Assays (500 ≤ plex ≤ 10,000) 1.4. Very High Density Multiplexed Assays (> 10,000-plex) 1.5. Next Generation Sequencing Assays 2. Application 2.1. Allergies 2.2. Autoimmune Diseases 2.3. Cardiac Diseases 2.4. Infectious Disease Diagnostic 2.5. Oncology 2.6. Pregnancy & Fertility Testing 3. End Users 3.1. Academic Research Institutes 3.2. Clinical Research Organizations 3.3. Diagnostic Laboratories 3.4. Hospital 3.5. Pharmaceutical Companies 4. Geography (Region, Country) 4.1. North America (U.S., Canada) 4.2. Latin America (Brazil, Mexico, Rest of LA) 4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 4.4. Asia Pacific (Japan, China, India, Rest of APAC) 4.5. Rest of the World 5. Company Profiles 5.1. Abbott Laboratories 5.2. Agilent Technologies 5.3. bioMérieux SA 5.4. Bio-Rad Laboratories, Inc. 5.5. F. Hoffmann-La Roche Ltd. 5.6. Hologic, Inc. 5.7. Illumina, Inc. 5.8. Luminex Corporation 5.9. Siemens Healthineers 5.10. Thermo Fisher Scientific, Inc. To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, April 27, 2017 --( PR.com )-- The development and implementation of highly multiplex molecular diagnostic tests have allowed clinical microbiology laboratories to more rapidly and sensitively detect a variety of pathogens directly in clinical specimens. The industry with new molecular diagnostic (MDx) tests is significantly less costly, while simultaneously increasing the number of targets per test through high multiplexing. The advanced technology has the potential to drive growth in the market, particularly in areas such as infectious disease testing, genetic analysis, and personalized medicine. Validation of a large number of disease markers in both molecular and protein diagnostics has paved the way for the emergence of the multiplex assay. The simple low-throughput multiplex assays followed by low-level multiplexing and high-throughput array-based immunoassays are replaced with two types of high-level multiplexing and high-throughput diagnostic methods using microspot arrays and bead arrays. Benefits of using multiplex molecular diagnostics array platforms include improved-quality patient care, as well as cost effectiveness and time saving.Browse Multiplexed Molecular Diagnostics Market by Technology (Low Density Multiplexed Assays, Medium Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays, Next Generation Sequencing Assays), Application (Allergies, Autoimmune Diseases, Cardiac Diseases, Infectious Disease Diagnostic, Oncology, Pregnancy & Fertility Testing), End Users (Academic Research Institutes, Clinical Research Organizations, Diagnostic Laboratories, Hospital, Pharmaceutical Companies) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/The global multiplexed molecular diagnostics market segmentation is based on technology (low density multiplexed assays, medium density multiplexed assays, high density multiplexed assays, very high density multiplexed assays, next generation sequencing assays), application (allergies, autoimmune diseases, cardiac diseases, infectious disease diagnostic, oncology, pregnancy & fertility testing), end users (academic research institutes, clinical research organizations, diagnostic laboratories, hospital, pharmaceutical companies).The global multiplexed molecular diagnostics market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global multiplexed diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global multiplexed molecular diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.Major players operating in the global multiplexed molecular diagnostics market and profiled in this report include Abbott Laboratories, Agilent Technologies, bioMérieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Luminex Corporation, Siemens Healthineers, and Thermo Fisher Scientific, Inc.1. Technology1.1. Low Density Multiplexed Assays (plex ≤ 5)1.2. Medium Density Multiplexed Assays (plex 10,000-plex)1.5. Next Generation Sequencing Assays2. Application2.1. Allergies2.2. Autoimmune Diseases2.3. Cardiac Diseases2.4. Infectious Disease Diagnostic2.5. Oncology2.6. Pregnancy & Fertility Testing3. End Users3.1. Academic Research Institutes3.2. Clinical Research Organizations3.3. Diagnostic Laboratories3.4. Hospital3.5. Pharmaceutical Companies4. Geography (Region, Country)4.1. North America (U.S., Canada)4.2. Latin America (Brazil, Mexico, Rest of LA)4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)4.4. Asia Pacific (Japan, China, India, Rest of APAC)4.5. Rest of the World5. Company Profiles5.1. Abbott Laboratories5.2. Agilent Technologies5.3. bioMérieux SA5.4. Bio-Rad Laboratories, Inc.5.5. F. Hoffmann-La Roche Ltd.5.6. Hologic, Inc.5.7. Illumina, Inc.5.8. Luminex Corporation5.9. Siemens Healthineers5.10. Thermo Fisher Scientific, Inc.To request Table of Contents and Sample Pages of this report visit:https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


Receive press releases from iHealthcareAnalyst, Inc.: By Email Global Multiplex Molecular Diagnostics Market by Technologies, Applications, End Users, Growth Trends and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc. Multiplex Molecular Diagnostics Market by Technology (Low Density Assays, High Density Assays, Very High Density Assays), Application (Allergies, Autoimmune Diseases, Cardiac Diseases, Infectious Disease Diagnostics, Oncology, Pregnancy & Fertility Testing), End Users (Academic Institutes, CROs, Diagnostic Labs, Hospital, Pharma Companies) and Forecast 2017-2021 Maryland Heights, MO, April 28, 2017 --( Browse Multiplex Molecular Diagnostics Market by Technology (Low Density Assays – Quantitative PCR, Microplate Assays, Medium Density Assays - Bead-based Arrays, Antibody Arrays, Reverse Arrays, Mass Spectrometry, High Density Assays - Bacterial Artificial Chromosome Arrays, Protein Arrays, Very High Density Assays - Oligonucleotide Arrays, Second Generation Sequencing, Phage Display), Application (Allergies, Autoimmune Diseases, Cardiac Diseases, Infectious Disease Diagnostics, Oncology, Pregnancy & Fertility Testing), End Users (Academic Research Institutes, Clinical Research Organizations, Diagnostic Laboratories, Hospital, Pharmaceutical Companies) and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/ The global multiplexed molecular diagnostics market segmentation is based on technology (low density multiplexed assays, microplate assays, quantitative PCR, medium density multiplexed assays, antibody arrays, bead-based arrays, mass spectrometry, reverse arrays, high density multiplexed assays, bacterial artificial chromosome arrays, protein arrays, very high density multiplexed assays, oligonucleotide arrays, phage display, next generation sequencing assays), and applications (allergies, autoimmune diseases, cardiac disorders, infectious disease diagnosis, oncology). The global multiplexed molecular diagnostics market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global multiplexed molecular diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global multiplexed molecular diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. Major players operating in the global multiplexed molecular diagnostics market and included in this report are Affymetrix, Agilent Technologies, Gen-Probe, Inc., bioMerieux, Luminex Corporation, Illumina, Inc. and Life Technologies (Thermo Fisher Scientific). 1. Technology 1.1. Low Density Assays (plex ≤ 5) 1.1.1. Quantitative PCR 1.1.2. Microplate Assays 1.2. Medium Density Assays (plex < 500) 1.2.1. Bead-based Arrays 1.2.2. Antibody Arrays 1.2.3. Reverse Arrays 1.2.4. Mass Spectrometry 1.3. High Density Assays (500 ≤ plex ≤ 10,000) 1.3.1. Bacterial Artificial Chromosome Arrays 1.3.2. Protein Arrays 1.4. Very High Density Assays (> 10,000-plex) 1.4.1. Oligonucleotide Arrays 1.4.2. Second Generation Sequencing 1.4.3. Phage Display 2. Application 2.1. Allergies 2.2. Autoimmune Diseases 2.3. Cardiac Diseases 2.4. Infectious Disease Diagnostic 2.5. Oncology 2.6. Pregnancy & Fertility Testing 3. End Users 3.1. Academic Research Institutes 3.2. Clinical Research Organizations 3.3. Diagnostic Laboratories 3.4. Hospital 3.5. Pharmaceutical Companies 4. Geography (Region, Country) 4.1. North America (U.S., Canada) 4.2. Latin America (Brazil, Mexico, Rest of LA) 4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 4.4. Asia Pacific (Japan, China, India, Rest of APAC) 4.5. Rest of the World 5. Company Profiles 5.1. Abbott Laboratories 5.2. Agilent Technologies 5.3. bioMérieux SA 5.4. Bio-Rad Laboratories, Inc. 5.5. F. Hoffmann-La Roche Ltd. 5.6. Hologic, Inc. 5.7. Illumina, Inc. 5.8. Luminex Corporation 5.9. Siemens Healthineers 5.10. Thermo Fisher Scientific, Inc. To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, April 28, 2017 --( PR.com )-- Multiplexed molecular diagnostics involves analyzing large number of target analytes present in biochemical substances, cells of an organism, or an organic sample for disease diagnosis, quantitatively as well as qualitatively. Multiplexed diagnostics assays are preferred over single plex assays considering its low cost, high throughout nature and less turnaround time. Multiplexed assays are also used in drug discovery and phases of clinical development in pharmaceutical industries, scientific research and genomic screening. Automation, technological advancement, widespread availability, and higher prevalence of cancer and infectious diseases has driven the growth of global multiplexed diagnostics market.Browse Multiplex Molecular Diagnostics Market by Technology (Low Density Assays – Quantitative PCR, Microplate Assays, Medium Density Assays - Bead-based Arrays, Antibody Arrays, Reverse Arrays, Mass Spectrometry, High Density Assays - Bacterial Artificial Chromosome Arrays, Protein Arrays, Very High Density Assays - Oligonucleotide Arrays, Second Generation Sequencing, Phage Display), Application (Allergies, Autoimmune Diseases, Cardiac Diseases, Infectious Disease Diagnostics, Oncology, Pregnancy & Fertility Testing), End Users (Academic Research Institutes, Clinical Research Organizations, Diagnostic Laboratories, Hospital, Pharmaceutical Companies) and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/The global multiplexed molecular diagnostics market segmentation is based on technology (low density multiplexed assays, microplate assays, quantitative PCR, medium density multiplexed assays, antibody arrays, bead-based arrays, mass spectrometry, reverse arrays, high density multiplexed assays, bacterial artificial chromosome arrays, protein arrays, very high density multiplexed assays, oligonucleotide arrays, phage display, next generation sequencing assays), and applications (allergies, autoimmune diseases, cardiac disorders, infectious disease diagnosis, oncology).The global multiplexed molecular diagnostics market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global multiplexed molecular diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global multiplexed molecular diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.Major players operating in the global multiplexed molecular diagnostics market and included in this report are Affymetrix, Agilent Technologies, Gen-Probe, Inc., bioMerieux, Luminex Corporation, Illumina, Inc. and Life Technologies (Thermo Fisher Scientific).1. Technology1.1. Low Density Assays (plex ≤ 5)1.1.1. Quantitative PCR1.1.2. Microplate Assays1.2. Medium Density Assays (plex 10,000-plex)1.4.1. Oligonucleotide Arrays1.4.2. Second Generation Sequencing1.4.3. Phage Display2. Application2.1. Allergies2.2. Autoimmune Diseases2.3. Cardiac Diseases2.4. Infectious Disease Diagnostic2.5. Oncology2.6. Pregnancy & Fertility Testing3. End Users3.1. Academic Research Institutes3.2. Clinical Research Organizations3.3. Diagnostic Laboratories3.4. Hospital3.5. Pharmaceutical Companies4. Geography (Region, Country)4.1. North America (U.S., Canada)4.2. Latin America (Brazil, Mexico, Rest of LA)4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)4.4. Asia Pacific (Japan, China, India, Rest of APAC)4.5. Rest of the World5. Company Profiles5.1. Abbott Laboratories5.2. Agilent Technologies5.3. bioMérieux SA5.4. Bio-Rad Laboratories, Inc.5.5. F. Hoffmann-La Roche Ltd.5.6. Hologic, Inc.5.7. Illumina, Inc.5.8. Luminex Corporation5.9. Siemens Healthineers5.10. Thermo Fisher Scientific, Inc.To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


Receive press releases from iHealthcareAnalyst, Inc.: By Email Hepatitis E Diagnostic Tests Market by Test Types, End Users, Growth Trends and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc. Hepatitis E Diagnostic Tests Market by Test Type (ELISA HEV IgM Test Kits, ELISA HEV IgG Test Kits, RT-PCR Test Kits, Others), End Users (Diagnostic Laboratories, Hospitals, Point-of-Care) and Forecast 2017-2021. Maryland Heights, MO, April 30, 2017 --( Browse Hepatitis E Diagnostic Tests Market by Test Type (ELISA HEV IgM Test Kits, ELISA HEV IgG Test Kits, RT-PCR Test Kits, Others), End Users (Diagnostic Laboratories, Hospitals, Point-of-Care) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/hepatitis-e-diagnostics-market/ The global hepatitis E diagnostic tests market segmentation is based on test type (ELISA HEV IgM test kits, ELISA HEV IgG test kits, RT-PCR test kits, Others), end users (diagnostic laboratories, hospitals, point-of-care). The global hepatitis E diagnostic tests market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global hepatitis E diagnostic tests market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global hepatitis E diagnostic tests market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. Major players operating in the global hepatitis E diagnostic tests market and profiled in this report include Altana Diagnostics GmbH, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Biokit S.A., Dia.Pro - Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd., Fast-track diagnostics Ltd., Fortress Diagnostics Limited, Mikrogen GmBH, MP Biomedicals, LLC, and Primerdesign Ltd. 1. Test Type 1.1. ELISA HEV IgM Test Kits 1.2. ELISA HEV IgG Test Kits 1.3. RT-PCR Test Kits 1.4. Others 2. End Users 2.1. Diagnostic Laboratories 2.2. Hospitals 2.3. Point-of-Care 2.4. Research Centers 3. Geography (Region, Country) 3.1. North America (U.S., Canada) 3.2. Latin America (Brazil, Mexico, Rest of LA) 3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 3.4. Asia Pacific (Japan, China, India, Rest of APAC) 3.5. Rest of the World 4. Company Profiles 4.1. Altana Diagnostics GmbH 4.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 4.3. Biokit S.A. 4.4. Dia.Pro - Diagnostic Bioprobes s.r.l 4.5. F. Hoffmann-La Roche Ltd. 4.6. Fast-track diagnostics Ltd. 4.7. Fortress Diagnostics Limited 4.8. Mikrogen GmBH 4.9. MP Biomedicals, LLC 4.10. Primerdesign Ltd. To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/hepatitis-e-diagnostics-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, April 30, 2017 --( PR.com )-- Hepatitis E is a liver disease caused by the hepatitis E virus (HEV), and the infection is found worldwide but most common in developing countries with limited access to essential water, sanitation, hygiene and health services. The commonly used tests for HEV infection include detection of IgM and IgG anti-HEV antibodies and detection of HEV RNA. Diagnosis of hepatitis E infection is usually based on the detection of specific IgM antibodies (ELISA). Additional tests include reverse transcriptase polymerase chain reaction (RT-PCR) to detect the hepatitis E virus RNA in blood and/or stool samples, carried out in specialized laboratory facilities. Recently, a test for viral antigen detection in serum has been developed. Although several diagnostic assays for anti-HEV antibodies are available, they have undergone fairly limited testing and often provide discordant results, particularly for IgG antibodies. Improved validation of existing anti-HEV antibody assays or development of new assays with superior performance characteristics is urgently needed.Browse Hepatitis E Diagnostic Tests Market by Test Type (ELISA HEV IgM Test Kits, ELISA HEV IgG Test Kits, RT-PCR Test Kits, Others), End Users (Diagnostic Laboratories, Hospitals, Point-of-Care) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/hepatitis-e-diagnostics-market/The global hepatitis E diagnostic tests market segmentation is based on test type (ELISA HEV IgM test kits, ELISA HEV IgG test kits, RT-PCR test kits, Others), end users (diagnostic laboratories, hospitals, point-of-care).The global hepatitis E diagnostic tests market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global hepatitis E diagnostic tests market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global hepatitis E diagnostic tests market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.Major players operating in the global hepatitis E diagnostic tests market and profiled in this report include Altana Diagnostics GmbH, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Biokit S.A., Dia.Pro - Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd., Fast-track diagnostics Ltd., Fortress Diagnostics Limited, Mikrogen GmBH, MP Biomedicals, LLC, and Primerdesign Ltd.1. Test Type1.1. ELISA HEV IgM Test Kits1.2. ELISA HEV IgG Test Kits1.3. RT-PCR Test Kits1.4. Others2. End Users2.1. Diagnostic Laboratories2.2. Hospitals2.3. Point-of-Care2.4. Research Centers3. Geography (Region, Country)3.1. North America (U.S., Canada)3.2. Latin America (Brazil, Mexico, Rest of LA)3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)3.4. Asia Pacific (Japan, China, India, Rest of APAC)3.5. Rest of the World4. Company Profiles4.1. Altana Diagnostics GmbH4.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.4.3. Biokit S.A.4.4. Dia.Pro - Diagnostic Bioprobes s.r.l4.5. F. Hoffmann-La Roche Ltd.4.6. Fast-track diagnostics Ltd.4.7. Fortress Diagnostics Limited4.8. Mikrogen GmBH4.9. MP Biomedicals, LLC4.10. Primerdesign Ltd.To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/hepatitis-e-diagnostics-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill DriveMaryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


Research and Markets has announced the addition of the "Global Endoscopy Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Endoscopy Market is poised to grow at a CAGR of around 6.9% over the next decade to reach approximately $47.6 billion by 2025. This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report is a valuable asset for the existing players, new entrants and the future investors. Some of the prominent trends that the market is witnessing include increasing miniaturization in scope system design, shift to HD (High Definition) and 3D systems, micro endoscope is breakthrough in endoscopy market and new and innovative multiband photonic and spectroscopic imaging methods for endoscopes. Key Topics Covered: 1 Market Outline 2 Executive Summary 3 Market Overview 3.1 Current Trends 3.1.1 Increasing miniaturization in scope system design 3.1.2 Shift to HD (High Definition) and 3D systems 3.1.3 Micro endoscope is breakthrough in endoscopy market 3.1.4 New and innovative multiband photonic and spectroscopic imaging methods for endoscopes 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness 4 Endoscopy Market, By Product 4.1 Capsule Endoscopes 4.2 Flexible Endoscopes 4.3 Rigid Endoscopes 4.4 Robot Assisted Endoscopes 4.5 Endoscopic Accessories 4.5.1.1 Cleaning Brushes 4.5.1.2 Fluid Flushing Devices 4.5.1.3 Biopsy Valves 4.5.1.4 Mouthpieces 4.5.1.5 Needle Forceps & Needle Holders 4.5.1.6 Light Cables 4.5.1.7 Surgical Dissectors 4.5.1.8 Other Accessories (Distal Attachments) 4.6 Endoscopic Visualization System 4.6.1.1 Endoscopic Light Sources 4.6.1.2 Endoscopic Cameras 4.6.1.2.1.1 Single-Chip Cameras 4.6.1.2.1.2 3-Chip Cameras 4.6.1.2.1.3 3D Cameras 4.6.1.2.1.4 HD Cameras 4.6.1.3 Camera Heads 4.6.1.4 Video Converters 4.6.1.5 Video Recorders 4.6.1.6 Video Processors 4.6.1.7 Carts 4.6.1.8 Transmitters & Receivers 4.6.1.9 Wireless Displays and Monitors 4.6.1.10 Other Visualization Devices 4.7 Endoscopy Instruments 4.7.1.1 Electronic Endoscopy Equipment 4.7.1.1.1 Endoscopy Ultrasounds (EUS) 4.7.1.1.2 Endoscopy Fluid Management Systems 4.7.1.1.3 Insufflators 4.7.1.1.4 Other Electronic Endoscopy Equipment 4.7.1.2 Mechanical Endoscopy Equipment 4.7.1.2.1.1 Graspers 4.7.1.2.1.2 Snares 4.7.1.2.1.3 Biopsy Forceps 4.7.1.2.1.4 Endoscopic Implants 4.7.1.2.1.5 Trocars and Cannulae 4.7.1.2.1.6 Other Mechanical Endoscopic Instruments 5 Endoscopy Market, By Application 5.1 Angioscope 5.1.1.1 Arthroscopy 5.1.1.2 Cystoscope 5.1.1.3 Hysteroscope 5.2 Choledochoscope 5.2.1.1 Duodenoscope 5.2.1.2 Enteroscope 5.3 ENT Endoscopy 5.4 Chromoendoscopy 5.5 Gastrointestinal (GI) Endoscopy 5.5.1.1 Colonoscope 5.5.1.2 Sigmoidoscope 5.6 Laparoscopy 5.7 Laryngoscopy 5.7.1.1 Bronchoscope 5.8 Mediastinoscopy 5.9 Resectoscope 5.9.1.1 Fetoscope 5.10 Otoscopy 5.11 Obstetrics/Gynecology Endoscopy 5.12 Urology Endoscopy (Cystoscopy) 5.13 Vascolo Surgery Endoscopy 5.14 Video Capsule Endoscopy 6 Endoscopy Market, By End User 6.1 Ambulatory Surgical Centers/Clinics 6.2 Hospitals 6.3 Diagnostic Laboratories 6.4 Academic Research Laboratories 6.5 Other End Users 6.5.1 Other End Users Market Forecast to 2025 (US$ MN) 7 Endoscopy Market, By Geography 8 Key Player Activities 8.1 Acquisitions & Mergers 8.2 Agreements, Partnerships, Collaborations and Joint Ventures 8.3 Product Launch & Expansions 8.4 Other Activities 10 Leading Companies 10.1 Cook Medical Incorporated 10.2 Boston Scientific Corporation 10.3 CapsoVision Inc 10.4 Chongqing Jinshan Science & Technology Co 10.5 Stryker Corporation 10.6 Fujifilm Holding Corporation 10.7 Given Imaging Ltd 10.8 Karl Storz GmbH & Co.Kg 10.9 Olympus Corporation 10.10 IntroMedic Co. Ltd 10.11 RF System Lab 10.12 Medtronic PLC 10.13 Pentax Medical (Hoya Corporation) 10.14 Richard Wolf GmbH 10.15 Smith & Nephew PLC 10.16 Ethicon, Inc 10.17 Maxer Medizintechnik 10.18 B. Braun Melsungen 10.19 Ventura Business Solutions For more information about this report visit http://www.researchandmarkets.com/research/dvstb8/global_endoscopy Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716


Global Pressure Monitoring Devices Market Forecast to 2024 – New Report by Data Bridge Market Research Global Pressure Monitoring Devices Market, By Product Type (Blood pressure, Pulmonary Pressure Monitors, Intraocular Pressure Monitors, Intracranial Pressure Monitors, Intracranial Pressure Monitors and Other Pressure Monitoring Devices), By Application (Respiratory Disorders, Glaucoma, Cardiac Disorders, Neurological Disorders, Dialysis), By Procedure (Non-invasive and Invasive), By End User, By Distribution Channel, By Geography – Industry Trends and Forecast to 2024 Dallas, TX, February 22, 2017 --( The global pressure monitoring devices market is segmented on the basis of product type, application, procedure, end-user, distribution channel and geography. On the basis of the product type the market is segmented into blood pressure (Automated BP Monitors, Ambulatory BP Monitors, Sphygmomanometers, BP Transducers), Pulmonary Pressure Monitors (Oximeters, Capnographs, Spirometers), Intraocular Pressure Monitors (Prisms, Prisms Sterilizers, Tip Covers, Sensors). Based on application the market is segmented into Respiratory Disorders, Glaucoma, Cardiac Disorders, Neurological Disorders and Dialysis. On the basis of Procedure the market is segmented into Invasive and Non-invasive. Based on end-user the market is segmented into Hospitals, Ambulatory Surgical Centres and Clinics, Diagnostic Laboratories, and Physician. Request for sample pages: https://databridgemarketresearch.com/reports/global-pressure-monitoring-devices-market/ Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa. The report includes company share data for different geographies including Global, North America, Europe and APAC. Read more: https://databridgemarketresearch.com/reports/global-pressure-monitoring-devices-market/ The key players operating in this market are Withings SA, Koninklijke Philips N.V., American Diagnostic Corporation, General Electric Company, Welch Allyn, OMRON HEALTHCARE Co. Ltd., A&D Medical, SunTech Medical, Inc., Spirit Medical Co., Briggs Healthcare, Drägerwerk AG & Co. KGaA, Siemens Healthcare GmbH, Medtronic, CAS Medical Systems, Inc., Rossmax International Ltd., GF HEALTH PRODUCTS, INC., OSI Systems, Inc., NIHON KOHDEN CORPORATION., Compumedics Limited, Electrical Geodesics, Inc. among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, February 22, 2017 --( PR.com )-- The Global Pressure Monitoring Devices Market is expected to reach USD 10.7 billion by 2024 from USD 6.5 billion in 2016, at a CAGR of 6.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.The global pressure monitoring devices market is segmented on the basis of product type, application, procedure, end-user, distribution channel and geography.On the basis of the product type the market is segmented into blood pressure (Automated BP Monitors, Ambulatory BP Monitors, Sphygmomanometers, BP Transducers), Pulmonary Pressure Monitors (Oximeters, Capnographs, Spirometers), Intraocular Pressure Monitors (Prisms, Prisms Sterilizers, Tip Covers, Sensors).Based on application the market is segmented into Respiratory Disorders, Glaucoma, Cardiac Disorders, Neurological Disorders and Dialysis.On the basis of Procedure the market is segmented into Invasive and Non-invasive.Based on end-user the market is segmented into Hospitals, Ambulatory Surgical Centres and Clinics, Diagnostic Laboratories, and Physician.Request for sample pages: https://databridgemarketresearch.com/reports/global-pressure-monitoring-devices-market/Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa. The report includes company share data for different geographies including Global, North America, Europe and APAC.Read more: https://databridgemarketresearch.com/reports/global-pressure-monitoring-devices-market/The key players operating in this market are Withings SA, Koninklijke Philips N.V., American Diagnostic Corporation, General Electric Company, Welch Allyn, OMRON HEALTHCARE Co. Ltd., A&D Medical, SunTech Medical, Inc., Spirit Medical Co., Briggs Healthcare, Drägerwerk AG & Co. KGaA, Siemens Healthcare GmbH, Medtronic, CAS Medical Systems, Inc., Rossmax International Ltd., GF HEALTH PRODUCTS, INC., OSI Systems, Inc., NIHON KOHDEN CORPORATION., Compumedics Limited, Electrical Geodesics, Inc. among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research


Research and Markets has announced the addition of the "Global Wireless Health Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Wireless Health Market is poised to grow at a CAGR of around 23.8% over the next decade to reach approximately $330.5 billion by 2025. This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. Some of the prominent trends that the market is witnessing include increased interest towards self care, rapid proliferation of smartphones and tablets and availability of economical wireless devices. Based on component, the market is categorized hardware and software. Depending on the application the market is segmented by medical & diagnostic laboratories, telehealth, healthcare amenities, home care, pharmaceuticals, physicians and other applications. By services, market is segregated by tablet PC, handheld device, pager health information, PDA, smartphone and mobile phone. Based on technology the market is categorized into WiMAX (Worldwide Interoperability for Microwave Access), WLAN/Wi-Fi, WWAN (Wireless Wide Area Network), WPAN (Wireless Personal Area Network). WWAN (Wireless Wide Area Network) segment is further sub-segmented into CDMA, 3G and 4G, General Packet Radio Service (GPRS) and Global Positioning System (GPS). WPAN (Wireless Personal Area Network) segment is further sub-segmented into Ultra-wide Band (UWB), ZigBee, RFID, RTLS, and IPS, Bluetooth, Z-wave and Ant+. Depending on the end user the market is segmented by payers, patients/individuals and providers. - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments 3 Market Overview 3.1 Current Trends 3.1.1 Increased interest towards self care 3.1.2 Rapid proliferation of smartphones and tablets 3.1.3 Availability of economical wireless devices 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness 4 Wireless Health Market, By Component 4.1 Hardware 4.1.1 Hardware Market Forecast to 2025 (US$ MN) 4.2 Software 4.2.1 Software Market Forecast to 2025 (US$ MN) 5 Wireless Health Market, By Application 5.1 Medical & Diagnostic Laboratories 5.1.1 Medical & Diagnostic Laboratories Market Forecast to 2025 (US$ MN) 5.2 Telehealth 5.2.1 Telehealth Market Forecast to 2025 (US$ MN) 5.3 Healthcare Amenities 5.3.1 Healthcare Amenities Market Forecast to 2025 (US$ MN) 5.4 Home Care 5.4.1 Home Care Market Forecast to 2025 (US$ MN) 5.5 Pharmaceuticals 5.5.1 Pharmaceuticals Market Forecast to 2025 (US$ MN) 5.6 Physicians 5.6.1 Physicians Market Forecast to 2025 (US$ MN) 5.7 Other Applications 5.7.1 Other Applications Market Forecast to 2025 (US$ MN) 6 Wireless Health Market, By Service 6.1 Tablet PC 6.1.1 Tablet PC Market Forecast to 2025 (US$ MN) 6.2 Handheld Device 6.2.1 Handheld Device Market Forecast to 2025 (US$ MN) 6.3 Pager Health Information 6.3.1 Pager Health Information Market Forecast to 2025 (US$ MN) 6.4 PDA 6.4.1 PDA Market Forecast to 2025 (US$ MN) 6.5 Smartphone 6.5.1 Smartphone Market Forecast to 2025 (US$ MN) 6.6 Mobile Phone 6.6.1 Mobile Phone Market Forecast to 2025 (US$ MN) 7 Wireless Health Market, By Technology 7.1 WiMAX (Worldwide Interoperability for Microwave Access) 7.1.1 WiMAX (Worldwide Interoperability for Microwave Access) Market Forecast to 2025 (US$ MN) 7.2 WLAN/Wi-Fi 7.2.1 WLAN/Wi-Fi Market Forecast to 2025 (US$ MN) 7.3 WWAN (Wireless Wide Area Network) 7.3.1 WWAN (Wireless Wide Area Network) Market Forecast to 2025 (US$ MN) 7.3.1.1 CDMA 7.3.1.1.1 CDMA Market Forecast to 2025 (US$ MN) 7.3.1.2 3G and 4G 7.3.1.2.1 3G and 4G Market Forecast to 2025 (US$ MN) 7.3.1.3 General Packet Radio Service (GPRS) 7.3.1.3.1 General Packet Radio Service (GPRS) Market Forecast to 2025 (US$ MN) 7.3.1.4 Global Positioning System (GPS) 7.3.1.4.1 Global Positioning System (GPS) Market Forecast to 2025 (US$ MN) 7.4 WPAN (Wireless Personal Area Network) 7.4.1 WPAN (Wireless Personal Area Network) Market Forecast to 2025 (US$ MN) 7.4.1.1 Ultra-wide Band (UWB) 7.4.1.1.1 Ultra-wide Band (UWB) Market Forecast to 2025 (US$ MN) 7.4.1.2 ZigBee 7.4.1.2.1 ZigBee Market Forecast to 2025 (US$ MN) 7.4.1.3 RFID, RTLS, and IPS 7.4.1.3.1 RFID, RTLS, and IPS Market Forecast to 2025 (US$ MN) 7.4.1.4 Bluetooth 7.4.1.4.1 Bluetooth Market Forecast to 2025 (US$ MN) 7.4.1.5 Z-wave 7.4.1.5.1 Z-wave Market Forecast to 2025 (US$ MN) 7.4.1.6 Ant+ 7.4.1.6.1 Ant+ Market Forecast to 2025 (US$ MN) 8 Wireless Health Market, By End User 8.1 Payers 8.1.1 Payers Market Forecast to 2025 (US$ MN) 8.2 Patients/Individuals 8.2.1 Patients/Individuals Market Forecast to 2025 (US$ MN) 8.3 Providers 8.3.1 Providers Market Forecast to 2025 (US$ MN) - AT&T, Inc. - Philips Healthcare - Aerohive Networks, Inc. - Verizon Communications, Inc. - Nihon Kohden Corporation - Allscripts Healthcare Solutions, Inc. - Mckesson Corporation - Siemens A.G. - GE Healthcare - Polar Electro Inc. - Cerner Corporation - Vocera Communication, Inc. - Alcatel-Lucent - Qualcomm, Inc. - Omron Corporation For more information about this report visit http://www.researchandmarkets.com/research/mz4msg/global_wireless


Research and Markets has announced the addition of the "Global Viral Molecular Diagnostics Market Analysis and Trends - Application, Technology, End User - Forecast to 2025" report to their offering. This industry report analyzes the global markets for Viral Molecular Diagnostics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. Some of the prominent trends that the market is Acceptance of personalized medicine and companion diagnostics, Growth in Proteomics and Genomics Research, Molecular diagnostic tools with new and complex platforms and Introduction of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Based on Application the market is categorized into Infectious diseases, Genetics, Blood Screening and Microbiology. The Infectious diseases segment is further divided into Hepatitis B virus (HBV), Hepatitis C virus (HCV), Human Immunodeficiency Virus (HIV) and Human Papillomavirus (HPV). Based on Technology the market is categorized into Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarrays, in situ Hybridization, DNA Sequencing and Next-Generation Sequencing and Other Technologies. The End User segment market is categorized into Hospitals, Diagnostic Laboratories, Academics Institutions and Other End Users. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors. - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments 3.1.3 Molecular diagnostic tools with new and complex platforms For more information about this report visit


News Article | February 22, 2017
Site: marketersmedia.com

— Europe, the Middle East and Africa Cell Counting Market including classification, application and industry chain overview; Then we deeply analyzed Europe, the Middle East and Africa growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate etc. In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Europe, the Middle East and Africa Cell Counting Market. Brief TOC for Cell Counting Market: 1 Introduction 1.1 Definition 1.2 Scope of the Study 1.3 Market Structure 2 Research Methodology 2.1 Research Process 2.2 Primary Research 2.3 Secondary Research 2.4 Forecast Model 3 Report Excerpt 4 Forecast Indicators 4.1 Introduction 4.2 Growth Drivers 4.3 Growth Barriers 4.4 Growth Opportunities 4.5 Macroecnomical Indicators 5 Market Analysis 6 Europe, the Middle East And Africa Cell Counting Market, By End Users 6.1 Introduction 6.2 Hospitals and Research Institutions 6.3 Diagnostic Laboratories 6.4 Pharmaceutical & Biotechnology Companies, and Cros 6.5 Others Continue… We are thankful for the support and assistance from Europe, the Middle East and Africa Cell Counting Market chain related technical experts and marketing experts during Research Team survey and interviews. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. For more information, please visit https://www.marketresearchfuture.com/

Loading Diagnostic Laboratories collaborators
Loading Diagnostic Laboratories collaborators